224 related articles for article (PubMed ID: 16448390)
1. Evidences of the gender-related differences in cardiac repolarization and the underlying mechanisms in different animal species and human.
Cheng J
Fundam Clin Pharmacol; 2006 Feb; 20(1):1-8. PubMed ID: 16448390
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
Abi-Gerges N; Philp K; Pollard C; Wakefield I; Hammond TG; Valentin JP
Fundam Clin Pharmacol; 2004 Apr; 18(2):139-51. PubMed ID: 15066127
[TBL] [Abstract][Full Text] [Related]
3. Drugs for men and women - how important is gender as a risk factor for TdP?
Coker SJ
Pharmacol Ther; 2008 Aug; 119(2):186-94. PubMed ID: 18472167
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in the proarrhythmic potential of QT-prolonging drugs.
Wolbrette D
Curr Womens Health Rep; 2002 Apr; 2(2):105-9. PubMed ID: 12116598
[TBL] [Abstract][Full Text] [Related]
5. Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.
Milberg P; Hilker E; Ramtin S; Cakir Y; Stypmann J; Engelen MA; Mönnig G; Osada N; Breithardt G; Haverkamp W; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):647-54. PubMed ID: 17388913
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in understanding sex differences in cardiac repolarization.
James AF; Choisy SC; Hancox JC
Prog Biophys Mol Biol; 2007 Jul; 94(3):265-319. PubMed ID: 15979693
[TBL] [Abstract][Full Text] [Related]
7. The influence of progesterone alone and in combination with estradiol on ventricular action potential duration and triangulation in response to potassium channel inhibition.
Tisdale JE; Overholser BR; Wroblewski HA; Sowinski KM
J Cardiovasc Electrophysiol; 2011 Mar; 22(3):325-31. PubMed ID: 20731743
[TBL] [Abstract][Full Text] [Related]
8. Gender disparity in cardiac electrophysiology: implications for cardiac safety pharmacology.
Jonsson MK; Vos MA; Duker G; Demolombe S; van Veen TA
Pharmacol Ther; 2010 Jul; 127(1):9-18. PubMed ID: 20462510
[TBL] [Abstract][Full Text] [Related]
9. Gender-related differences of ventricular repolarization in LQT2 rabbit model.
Liu LP; Yang L; Zhao Z; Chen Q
Sheng Li Xue Bao; 2005 Dec; 57(6):749-54. PubMed ID: 16344901
[TBL] [Abstract][Full Text] [Related]
10. Gender-related differences in ventricular myocyte repolarization in the guinea pig.
James AF; Arberry LA; Hancox JC
Basic Res Cardiol; 2004 May; 99(3):183-92. PubMed ID: 15088103
[TBL] [Abstract][Full Text] [Related]
11. In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.
Lu HR; Vlaminckx E; Van de Water A; Rohrbacher J; Hermans A; Gallacher DJ
Eur J Pharmacol; 2006 Dec; 553(1-3):229-39. PubMed ID: 17054943
[TBL] [Abstract][Full Text] [Related]
12. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation.
Takahara A; Sugiyama A; Hashimoto K
Br J Pharmacol; 2005 Oct; 146(4):561-7. PubMed ID: 16056235
[TBL] [Abstract][Full Text] [Related]
13. Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3.
Milberg P; Reinsch N; Osada N; Wasmer K; Mönnig G; Stypmann J; Breithardt G; Haverkamp W; Eckardt L
Basic Res Cardiol; 2005 Jul; 100(4):365-71. PubMed ID: 15944809
[TBL] [Abstract][Full Text] [Related]
14. Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes.
Antzelevitch C
Heart Rhythm; 2005 Nov; 2(2 Suppl):S9-15. PubMed ID: 16253930
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in autonomic modulation of ventricular repolarization in humans.
Nakagawa M; Ooie T; Ou B; Ichinose M; Takahashi N; Hara M; Yonemochi H; Saikawa T
J Cardiovasc Electrophysiol; 2005 Mar; 16(3):278-84. PubMed ID: 15817086
[TBL] [Abstract][Full Text] [Related]
16. Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3.
Milberg P; Reinsch N; Wasmer K; Mönnig G; Stypmann J; Osada N; Breithardt G; Haverkamp W; Eckardt L
Cardiovasc Res; 2005 Feb; 65(2):397-404. PubMed ID: 15639478
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced long QT and torsade de pointes: recent advances.
Kannankeril PJ; Roden DM
Curr Opin Cardiol; 2007 Jan; 22(1):39-43. PubMed ID: 17143043
[TBL] [Abstract][Full Text] [Related]
18. Experimental study on the mechanism of sex difference in the risk of torsade de pointes.
Ruan YF; Liu N; Zhou Q; Li Y; Wang L
Chin Med J (Engl); 2004 Apr; 117(4):538-41. PubMed ID: 15109445
[TBL] [Abstract][Full Text] [Related]
19. Torsades, sex hormones, and ventricular repolarization.
Ciaccio EJ
J Cardiovasc Electrophysiol; 2011 Mar; 22(3):332-3. PubMed ID: 21040096
[No Abstract] [Full Text] [Related]
20. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
